Eli Lilly & Co. (LLY), Takeda Lose Bid to Overturn $9B Actos Award
Tweet Send to a Friend
Eli Lilly (NYSE: LLY) and Takeda Pharma lost a bid to overturn a $9 billion punitive damage award linked to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
